This is the conclusion of Richard Posner and Tomas Philipson in a 1999 paper for the National Bureau of Economic Research.

FORBES: Fat And Happy In Oak Brook And Beijing

It is being brought forth by Dr. Andrew von Eschenbach, a former commissioner of the FDA and Dr. Tomas Philipson of the University of Chicago.

FORBES: Importance of a Drug's "Risk-Benefit" Profile Eludes Former FDA Commissioner